We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AnaptysBio Inc | NASDAQ:ANAB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.78 | 25.77 | 37.59 | 0 | 13:17:11 |
Delaware | 001-37985 | 20-3828755 | ||||||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||||
Common Stock, par value $0.001 per share
|
ANAB
|
The Nasdaq Stock Market LLC
|
Exhibit Number | Exhibit Title or Description | ||||
Press release issued by AnaptysBio, Inc. regarding its financial results for the three and nine months ended September 30, 2020, dated November 4, 2020
|
|||||
104 |
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
|
AnaptysBio, Inc. | |||||||||||
Date: November 4, 2020
|
By: | /s/ Dennis Mulroy | |||||||||
Name: Dennis Mulroy | |||||||||||
Title: Chief Financial Officer |
1 Year AnaptysBio Chart |
1 Month AnaptysBio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions